News

This new CHIPS platform provides a crucial technological bridge between foundational FRESH™ 3D bioprinting capabilities and ...
The work, led by Dr. Adam Feinberg and colleagues at Carnegie Mellon University, demonstrates the ability to fabricate centimeter-scale tissue constructs combining cells and extracellular matrix with ...
In a lawsuit filed Thursday in a New Jersey federal court, Halozyme alleges that a proposed subcutaneous formulation of Merck’s popular cancer drug Keytruda infringes 15 of its patents.
Micro decisions can have macro consequences. A soft matter physicist reveals how interactions within simple cellular ...
Opdivo Qvantig and Tecentriq Hybreza both rely on Halozyme's hyaluronidase technology, which temporarily hydrolyses hyaluronan in the extracellular matrix of the subcutaneous layer of skin ...
A fire damaged a home in the Toro Park neighborhood of Monterey County earlier today, but fortunately, no one was home, and officials responded quickly.The fire occurred on Capote Drive, just off ...
A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year.
WE wish to suggest a structure for the salt of deoxyribose nucleic acid (D.N.A.). This structure has novel features which are of considerable biological interest. A structure for nucleic acid has ...
No heads up. I have to coordinate all Matrix correspondence with my doctor. After surgery SAME THING. I follow up to find out they didn't reach my HCP for proof of surgery. NO HEADS UP.
This study highlights lumican as a promising biomarker for predicting the onset and progression of diabetic nephropathy and reveals its close association with extracellular matrix remodeling, a ...